Alnylam Pharmaceuticals, Inc. (ALNY)

NASDAQ: ALNY · Real-Time Price · USD

286.98

-6.47 (-2.20%)

At close: May 15, 2026, 4:00 PM EDT

293.80

+6.82 (2.38%)

After-hours: May 15, 2026, 7:34 PM EDT

Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	38,315	52,639	30,424	24,078	29,451	20,381
Market Cap Growth	15.18%	73.02%	26.36%	-18.24%	44.51%	34.69%
Enterprise Value	38,276	50,964	28,984	22,903	28,537	18,902
Last Close Price	286.98	397.65	235.31	191.41	237.65	169.58
PE Ratio	72.65	170.67	-107.94	-54.38	-25.55	-23.55
Forward PE	34.90	60.03	-	-	-	-
PS Ratio	8.94	14.17	13.53	13.17	28.39	24.14
PB Ratio	35.61	66.70	453.50	-109.13	-186.13	34.65
P/TBV Ratio	36.19	67.86	447.73	-108.36	-182.78	34.15
P/FCF Ratio	59.56	113.11	-714.37	574.04	-48.02	-28.38
P/OCF Ratio	53.60	100.44	-3660.27	231.18	-54.41	-31.76
EV/Sales Ratio	8.93	13.72	12.89	12.53	27.51	22.39
EV/EBITDA Ratio	47.43	91.46	-241.10	-100.40	-38.53	-28.59
EV/EBIT Ratio	50.89	101.61	-163.86	-81.17	-36.35	-26.67
EV/FCF Ratio	59.50	109.51	-680.55	546.02	-46.53	-26.32
Debt / Equity Ratio	1.14	1.56	18.69	-5.73	-8.08	1.63
Debt / EBITDA Ratio	1.58	2.29	-10.78	-5.72	-1.78	-1.51
Debt / FCF Ratio	1.98	2.75	-30.43	31.12	-2.15	-1.39
Net Debt / Equity Ratio	-1.61	-2.07	-20.84	5.14	5.51	-2.44
Net Debt / EBITDA Ratio	-2.15	-2.92	11.63	4.97	1.18	2.17
Net Debt / FCF Ratio	-2.70	-3.50	32.84	-27.03	1.42	2.00
Asset Turnover	0.85	0.81	0.56	0.50	0.29	0.24
Inventory Turnover	9.86	8.46	3.86	2.85	1.57	1.73
Quick Ratio	2.88	2.51	2.61	2.86	3.16	3.79
Current Ratio	3.13	2.76	2.78	3.08	3.51	4.04
Return on Equity (ROE)	61.91%	73.28%	362.29%	232.40%	-526.14%	-106.31%
Return on Assets (ROA)	14.67%	10.58%	-3.23%	-7.77%	-21.92%	-20.12%
Return on Invested Capital (ROIC)	77.56%	63.85%	-20.29%	-43.01%	-108.72%	-76.10%
Return on Capital Employed (ROCE)	20.66%	15.31%	-5.98%	-10.01%	-27.42%	-24.57%
Earnings Yield	1.40%	0.59%	-0.93%	-1.84%	-3.91%	-4.25%
FCF Yield	1.68%	0.88%	-0.14%	0.17%	-2.08%	-3.52%
Buyback Yield / Dilution	-6.45%	-5.51%	-2.20%	-2.64%	-2.73%	-3.01%
Total Shareholder Return	-6.45%	-5.51%	-2.20%	-2.64%	-2.73%	-3.01%

Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q